Shares of spinal implant manufacturer Globus Medical, Inc. (GMED) are rising in their trading debut on the New York Stock Exchange Friday, following a successful initial public offering.
The Audubon, Pennsylvania-based company priced its initial public offering of about 8.3 million shares of Class A common stock, consisting of about 2.1 million shares offered by Globus Medical and 6.25 million shares offered by selling shareholders, at $12 per share, the low end of an expected $12 to $13 range.
In addition, Globus Medical has granted the underwriters a 30-day option to purchase up to an additional 1.25 million shares of common stock to cover any over-allotments.
The offering is expected to close on August 8.
Earlier this week, Globus Medical reduced its planned IPO size to 8.3 million shares and estimated price range to $12 to $13 per share from its earlier plan to sell 11.8 million shares in a price range of $16 to $18 per share.
Globus Medical shares are currently trading at $13.99 after trading as high as $14.65 earlier in the session.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.